Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
In. CASMU. Investigación clínica: desarrollo e innovación, 2019. Montevideo, Ideas Uruguay, 2019. p.187-190.
Monografia em Espanhol | LILACS, UY-BNMED, BNUY | ID: biblio-1359542
2.
Pharmacology ; 91(1-2): 35-8, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23146926

RESUMO

No published studies have evaluated quality of life (QOL) with the 36-item Short Form Health Survey (SF-36) in subjects with chronic stable angina pectoris (CSAP). We evaluated whether a 1-month treatment with 10 mg ivabradine (IVA) or ß-blockers (bisoprolol 2.5 mg/day, carvedilol 12.5 mg/day, atenolol 50 mg/day) improves the QOL in patients with CSAP. The SF-36 was administered to 238 patients randomized in two groups. QOL and heart rate (HR) results after 1 month of therapy with IVA and ß-blockers (T1) were compared with basal values (T0). Treatments in both groups significantly reduced HR (-11 bpm at T1 compared with T0 in the IVA group, -7 bpm at T1 compared with T0 in the ß-blocker group), but IVA demonstrated a more significant (p < 0.001) reduction in HR than ß-blocker treatment (p < 0.01). We observed a significant improvement in all QOL dimensions in the group treated with IVA, in particular in the sections regarding physical functioning, physical role, and general health (p < 0.001). In the group treated with ß-blockers, we found statistically significant improvement only in the physical functioning and physical role sections (p < 0.01). With ß-blocker treatment, many questionnaire sections showed no statistically significant improvement (body pain, social functioning, emotional role, and mental component summary). IVA treatment significantly improves all aspects of QOL in patients with CSAP, unlike ß-blocker treatment. This improvement is associated with a greater reduction in HR.


Assuntos
Antagonistas Adrenérgicos beta/uso terapêutico , Angina Estável/tratamento farmacológico , Benzazepinas/uso terapêutico , Qualidade de Vida , Idoso , Atenolol/uso terapêutico , Bisoprolol/uso terapêutico , Carbazóis/uso terapêutico , Carvedilol , Feminino , Inquéritos Epidemiológicos , Humanos , Ivabradina , Masculino , Pessoa de Meia-Idade , Propanolaminas/uso terapêutico
3.
Hautarzt ; 38(4): 232-4, 1987 Apr.
Artigo em Alemão | MEDLINE | ID: mdl-3597091

RESUMO

A patient suffering from a metastasizing malignant melanoma of the skin developed diffuse melanosis of the skin and melanuria a few weeks before death occurred. At autopsy, disseminated metastases of malignant melanoma were associated with marked melanosis of the organs and particularly of the mononuclear phagocytic system. In addition, neutrophilic granulocytes of the peripheral blood frequently contained melanin granules. The presence of melanin in blood monocytes and granulocytes may be useful for the diagnosis of (metastasizing) malignant melanoma.


Assuntos
Macrófagos/patologia , Melanoma/patologia , Melanose/patologia , Neoplasias Cutâneas/patologia , Humanos , Masculino , Pessoa de Meia-Idade , Monócitos/patologia , Metástase Neoplásica , Neutrófilos/patologia , Pele/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA